Drug name - Beleodaq

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6888027 ACROTECH Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
Aug, 2026

(3 years from now)

EP1328510B1 ACROTECH (E)-N-Hydroxy-3-(3-Sulfamoyl-Phenyl)-Acrylamide Compounds And Their Therapeutic Use
Sep, 2021

(a year ago)

EP1328510A2 ACROTECH (E)-N-Hydroxy-3-(3-Sulfamoyl-Phenyl)-Acrylamide Compounds And Their Therapeutic Use
Sep, 2021

(a year ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8835501 ACROTECH Pharmaceutical formulations of HDAC inhibitors Oct, 2027

(5 years from now)

Drugs and Companies using BELINOSTAT ingredient

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
500MG/VIAL POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.